A population-based study included nearly 4000 patients diagnosed with AML from 2000 to 2016 in Denmark.
Although iron regulatory proteins (IRPs) may not be essential to the proliferation of stem and progenitor cells, IRPs are vital in later hematopoiesis.
According to a UK-based survery, a large number of people with hemoglobinopathies were infected with SARS-CoV-2 but COVID-19-related death was not linked.
This analysis focused on the allo-HSCT-related end points in a study of patients with newly diagnosed Ph+ ALL treated with a 2-step dasatinib-containing induction regimen.
Inotuzumab ozogamicin instead of gemcitabine added to R-CVP did not improve OS or PFS, but less toxicity among patients with untreated DLBCL with comorbid conditions.
The purpose of this study was to determine if a cytoreductive agent could provide additional efficacy to treat blood hyperviscosity.
Among adult patients with newly diagnosed AML, the presence of an FLT3-ITD mutation with an insertion site in the beta1-sheet was associated shorter survival.
Aside from hemostasis defect, patients with gray platelet syndrome may also have a loss of immune homeostasis.